This page lists the SEC filings reported by Blue Water Life Science Advisors, LP.
Type | Filed | |
---|---|---|
N-PX | 2024-08-30 | EDGAR |
SC 13G | 2024-08-28 | EDGAR |
13F-HR | 2024-08-09 | EDGAR |
13F-HR | 2024-05-15 | EDGAR |
13F-HR | 2024-02-14 | EDGAR |
13F-HR | 2023-11-14 | EDGAR |
13F-HR | 2023-08-14 | EDGAR |
13F-HR | 2023-05-15 | EDGAR |
13F-HR | 2023-02-14 | EDGAR |
13F-HR | 2022-11-14 | EDGAR |
13F-HR | 2022-08-15 | EDGAR |
13F-HR | 2022-05-18 | EDGAR |
13F-HR | 2022-02-14 | EDGAR |
13F-HR | 2021-11-15 | EDGAR |
13F-HR | 2021-08-13 | EDGAR |
13F-HR/A | 2021-05-14 | EDGAR |
13F-HR | 2021-05-14 | EDGAR |
13F-HR | 2021-02-16 | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.